Marco A. Zarbin, MD, PhD, of Rutger New Jersey Medical School, USA, speaks about the use of anti-VEGF agents to treat diabetic retinopathy, explaining when we should intervene based on the evidence from trials.
Marco A. Zarbin, MD, PhD, of Rutger New Jersey Medical School, USA, speaks about the use of anti-VEGF agents to treat diabetic retinopathy, explaining when we should intervene based on the evidence from trials.